Cannabis finance news

Zelira

Company news: Zelira Therapeutics; Argent Biopharma

by Steve Jones July 16, 2024November 25, 2024

Shares in Zelira Therapeutics soared more than 60% after securing patents from the Australian and US […]

Martin Lane - Cannabis Australia - Cannabiz

Cannabiz is four: what’s the point?

by Martin Lane July 15, 2024November 25, 2024

We’ll rebuild the company, insists Epsilon board, as internal review gets underway

by Steve Jones July 10, 2024July 10, 2024

Company news: ECS Botanics; Althea; InhaleRx; Neurotech International

by Martin Lane and Steve Jones July 10, 2024July 11, 2024

Company news: Zelira Therapeutics; Ecofibre; Cann Group; InhaleRx; Argent Biopharma; Melodiol Global Health; Wellnex Life

by Steve Jones July 4, 2024November 25, 2024

Long wait nearly over for Epsilon Healthcare creditors

by Steve Jones June 26, 2024June 26, 2024

Ecofibre orders debt restructuring plan after property sale falls through

by Steve Jones June 26, 2024September 4, 2024

Consolidation could be a survival strategy for many local growers

by Peter Koetsier June 25, 2024June 25, 2024

ECC Pharm to save ‘a fortune’ after offloading HAPA distribution division

by Steve Jones June 20, 2024June 20, 2024

It may seem crazy, but there is a path to quality patient care – and profitability

by Peter Koetsier June 19, 2024June 19, 2024